Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves new pain drug Journavx
What Is Journavx, the New Opioid-Free Painkiller from Vertex?
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment
New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids
Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, surgeries, and other injuries and procedures.
What to Know: FDA Approves Non-Opioid Pain Medication, Journavx
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.
Hosted on MSN
34m
Non-Opioid Pain Medication Journavx Gets FDA Approval
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
7h
What's Happening With VRTX Stock?
With a rise in Trikafta demand, the investors have assigned a higher valuation multiple for VRTX stock. The increase in VRTX ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
New tariffs coming Saturday
Los Angeles wildfire updates
Black boxes recovered
Todd exits NBC News
Cause of death revealed
Apologizes for old tweets
Granted legal personhood
Cancerous tumor removed
Activists call for boycott
Top leaders asked to resign
Hamas confirms death
2 more victims in indictment
'As Tears Go By' singer dies
Olympic gold medalist dies
US inflation ticked higher
Shiffrin finishes 10th
Inmate's transfer blocked
Michigan priest loses license
Recuses self from Act 10 suit
To raise hourly pay
S3 release date revealed
DOJ sues to block deal
Ground stop amid IT outage
Confirmed interior secretary
Searching for joyriders
FDA approves painkiller
Partners w/ US national labs
Feedback